Use of recombinant Von Willebrand factor during transcatheter aortic valve replacement in a patient with acquired von Willebrand syndrome

Transfus Med. 2021 Apr;31(2):142-144. doi: 10.1111/tme.12765. Epub 2021 Feb 24.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Transcatheter Aortic Valve Replacement* / adverse effects
  • von Willebrand Diseases* / surgery
  • von Willebrand Factor

Substances

  • von Willebrand Factor